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Summary In a prospective study of about 22,000 men attending a screening centre, serum samples were
collected and stored. The concentration of vitamin E (alpha-tocopherol) was measured in the stored serum
samples from 271 men subsequently notified as having cancer and from 533 unaffected controls, matched for
age, smoking history and duration of storage of the serum samples. The mean vitamin E level of the cancer
subjects was not significantly different from that of their matched controls. The mean level in the cancer
subjects who were diagnosed as having cancer before the elapse of one year from the date of blood collection
was, however, significantly lower than the mean concentration of their matched controls (10.0 and 11.5mgl-l
respectively, P=0.003). For subjects whose cancers were diagnosed one or more years after blood collection
the difference was not statistically significant either for all cancers or for cancers of six sites considered
separately, vi-. lung, colon and rectum, stomach, bladder, central nervous system and skin. The most likely
explanation for these results is that the low vitamin E levels observed in these subjects were a metabolic
consequence, rather than a precursor, of the cancer. This would explain, at least in part, the overall inverse
association between serum vitamin E and risk of cancer observed in the published epidemiological studies on
serum vitamin E and cancer.
Thcre is evidence to suggest that vitamin E (alpha-toco- way 533 matched controls were identified and tested, 9 less
pherol) may play a role in reducing the incidence of cancer. than the intended 542 because for 9 subjects serum from one
Vitamin E is a powerful anti-oxidant, a free radical of the 2 controls was spoilt in transport prior to assay. The
scavenger that inhibits lipid peroxidation (Burton et al., 1983; vitamin E (alpha-tocopherol) estimations were performed by
Burton & Ingold, 1981). This process is important in high pressure liquid chromatography (Vuilleumier et al.,
maintaining the integrity of cell membranes (Diplock, 1983). 1983). Samples were tested in four separate series, two in
Vitamin E supplementation has been shown to reduce the 1981, one in 1983 and one in 1985. Sera from subjects and
number and incidence of chemically induced tumours in their matched controls were always assayed in the same
animals (Haber & Wissler, 1962; Harmon, 1969; Cook & analytical batch. All the mean values of vitamin E presented
McNamara, 1980) although some studies failed to show such are adjusted for series, to take account of any changes in
an effect (Reddy & Tanaka, 1986; Toth & Patil, 1983). assay performance between series, but the (2-sided) P-values
To investigate whether vitamin E was related to the future given for comparing these means are derived from analyses
incidence of cancer in man, we conducted a prospective of variance adjusting for all the variables on which the
study of serum vitamin E in men attending a medical matching of cases and controls was based. (An analysis
screening centre in London. based on the values of log (vitamin E+5), for which the
overall distribution was approximately normal, did not alter
the interpretation of the results presented.) Relative risks
were estimated using logistic regression for matched sets
Subjects and methods (Breslow & Day, 1980).
The design of the prospective study has been described
before (Wald et al., 1980, 1986). In summary, blood was Results
collected from about 22,000 men aged 35-64 years who
attended the British United Provident Association (BUPA) The mean vitamin E concentration for all the cancer subjects
Medical Centre in London for a comprehensive medical was similar to that for their controls (10.1 and 10.3mgl-l
examination (including a serum cholesterol estimation) respectively). The overall mean was 10.2mg1- (standard
between 1975 and 1982. Serum was separated from the blood deviation 4.0mgl-1). Table I shows the mean vitamin E
sample and stored at -40 C. The National Health Service concentration of subjects and matched controls classified
records of these men were flagged and, through the according to the site of the cancer and the interval between
assistance of the Office of Population Censuses and Surveys, blood collection and the diagnosis of cancer. Specific cancer
notification was received in the event of a diagnosis of sites were analysed separately if 15 or more men had
cancer or death. By April 1985, 271 men were identified as developed cancer at that site. Stomach cancer (13 subjects)
having developed cancer (subjects) who had provided was also considered separately, but other sites were grouped
sufficient serum that was available for vitamin E analysis. together. There was a statistically significant difference in
Two controls were selected for each of the subjects, matched serum vitamin E levels between subjects whose cancers were
on age (within 5 years), duration of storage of the serum diagnosed before the elapse of one year from the date of
sample (within 3 months), smoking status (current smoker, blood collection and their matched controls (10.0 and
ex-smoker or life-long non-smoker) and, for current 11.5 mg1-is respectively, P=0.003). For subjects whose
smokers, smoking habits - type of product smoked cancers were diagnosed one or more years after blood
(cigarette, cigar or pipe), amount smoked (within 5 cigarettes collection the difference was not statistically significant and
per day, two cigars per day or an ounce of tobacco per for these 'late' cases there was no suggestion of a difference
week) and age of starting to smoke (within 5 years). In this in vitamin E levels between subjects and controls for cancer
on _n_r __(witin _____________i_t _______t_r cr at any of the specified sites (Table I). Indeed, the subject-
*PrcscIit address: Clinical Trial Scrvicc Unit, Raldcliffc Infilrmary, control differences in these 'late' cases and the 'early' ones
Oxford, 0X2 6HE, UK. diagnosed before the elapse of one year since blood
Correspondence: N.J. Wald. collection were statistically significantly different (P=0.01)
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Table I Mean serum vitamin E concentration (mg- 1) in cancer subjects and matched controls according to interval
between blood collection and diagnosis of cancer and according to site of cancer
Diagnosis ofcancerfrom time ofblood collection
Before I year 1-2 years 3 or more years Allperiods
Site of No. Mean No. Mean No. Mean No. Mean
cancer men vit E Diff' men vit E Difj' men vit E Diff men vit E Difj
Lung Subjects 9 9.2 -1.5 12 9.3 -0.8 29 9.0 +0.1 50 9.1 -0.4
Controls 17 10.7 24 10.1 58 8.9 99 9.5
Colo-rectal Subjects 6 10.7 -1.5 8 11.6 +1.9 16 9.5 -1.1 30 10.3 -0.4
Controls 12 12.2 15 9.7 32 10.6 59 10.7
Stomach Subjects 3 11.3 -0.8 5 13.5 +2.5 5 9.4 -0.7 13 11.4 +0.5
Controls 6 12.1 10 11.0 10 10.1 26 10.9
Bladder Subjects 8 10.7 +0.3 3 9.4 -2.5 4 11.4 +2.0 15 10.6 +0.2
Controls 15 10.4 6 11.9 8 9.4 29 10.4
CNSb Subjects 5 8.4 -2.0 3 11.3 + 1.1 9 9.9 +0.8 17 9.7 0.0
Controls 10 10.4 6 10.2 18 9.1 34 9.7
Skin Subjects 31 10.4 -1.6 9 11.1 -0.4 16 10.4 +0.9 56 10.5 -0.7
Controls 57 12.0 18 11.5 32 9.5 107 11.2
Other sites Subjects 28 9.8 -1.7 21 10.7 +0.1 41 9.8 +0.7 90 10.0 -0.2
Controls 55 11.5 42 10.6 82 9.1 179 10.2
All sites Subjects 90 10.0 -1.5c 61 10.8 +0.2 120 9.7 +0.3 271 10.1 -0.2
Controls 172 11.5 121 10.6 240 9.4 533 10.3
aDiff=difference; mean in cancer subjects minus mean in controls; bCentral nervous system; CP=0.003 (the only
statistically significant difference amongst differences in the marginal totals of the table - each cancer site or each period to
diagnosis).
Table II Relative risks of cancer according to vitamin E concentration (mg1-1) and interval
between blood collection and diagnosis of cancer
Diagnosis ofcancerfrom time ofblood collection
Vitamin E Before one year After one or more years
concentration
No. of: No. of:
Limits Relative Relative
Quintile (mg1-1) subjects controls riska subjects controls riska
1st <0.5- 16 17 1.89 42 86 0.98
2nd 7.4- 18 22 1.56 40 82 0.98
3rd 9.2- 19 37 0.95 37 65 1.14
4th 10.7- 20 41 0.86 30 70 0.84
5th 12.5-34.5 17 55 0.52 32 58 1.12
All <0.5-34.5 90 172 1.OOa 181 361 1.OOa
aRelative risks take into account the matched design of the study and are expressed relative to
the risk in the 'all' category.
The trend in relative risks for cancer subjects diagnosed before 1 year is statistically
significant (P=0.003).
Some have suggested that vitamin E expressed as a ratio vitamin E and the risk of cancer that was restricted to men
to the serum cholesterol level (vitamin E is transported in who were diagnosed as having cancer before the elapse of
blood mainly by low density lipoprotein) may be biologically one year from the date of blood collection. This suggests
more relevant than vitamin E concentration alone (Horwitt that the low serum vitamin E levels were a metabolic
et al., 1972). Expressing the results in this way, or adjusting consequence, rather than a precursor, of the cancer, even
vitamin E levels for serum cholesterol in an analysis of
variance, decreased the significance of the difference in Table III Mean vitamin E concentrations (mglF1) in cancer
vitamin E relating to the 'early' cases but did not alter the subjects and controls according to age at blood collection
conclusions.
Table II shows the number of subjects and controls and Cancer subjects Controls All
relative risk of cancer according to the quintile of serum
vitamin E concentration. There was a statistically significant Age No. Mean No. Mean No. Mean
inverse trend in relative risk among the subjects in whom the (years) men vitamin E men vitamin E men vitamin E s.e.
diagnosis was made before the elapse of one year from blood
collection, but this was not the case for those diagnosed 40A44 27 10.3 64 10.1 91 10.1 0.4
later. 45-49 49 10.5 83 10.2 132 10.3 0.4
50-54 57 10.0 121 10.8 178 10.5 0.3
55-59 63 9.7 140 10.2 203 10.0 0.2
Discussion 60-64 65 10.2 102 10.2 167 10.2 0.3
All 271 10.1 533 10.3 804 10.2 0.1 We have demonstrated an inverse association between serumSERUM VITAMIN E AND SUBSEQUENT RISK OF CANCER 71
Table IV Mean vitamin E concentrations (mgl-1) in cancer subjects and
controls according to smoking status and stated cigarette consumption at the time
of blood collection
Cancer subjects Controls All
No. Mean No. Mean No. Mean
Smoking category men vitamin E men vitamin E men vitamin E s.e.
Life-long
non-smokers 47 9.9 93 10.6 140 10.4 0.4
Ex-smokers 88 10.4 175 10.7 263 10.6 0.3
Smokers of
cigarettes alone:
1-9/day 14 11.4 19 9.4 33 10.3 0.7
10-19/day 20 9.1 33 10.1 53 9.7 0.4
20-29/day 19 10.0 49 9.4 68 9.6 0.4
30 or more/day 25 9.5 43 9.6 68 9.6 0.3
All 78 9.9 144 9.6 222 9.7 0.2
Other
smokers 58 9.9 121 10.4 179 10.3 0.3
Table V Mean vitamin E concentrations (mgI1) in cancer subjects The results of this study, together with those previously
and controls according to duration of storage of the serum sample published on serum retinol and cancer (Wald et al., 1980)
and those on serum cholesterol and cancer (Rose & Shipley,
Cancer subjects Controls All 1980), demonstrate the importance of considering the
Storage relationship between a biochemical measurement in subjects
time No. Mean No. Mean No. Mean who develop cancer according to the interval between blood
(years) men vitamin E men vitamin E men vitamin E s.e. collection and diagnosis of the cancer. Only by doing so can
<3 26 10.1 50 11.0 76 10.7 0.3 cause and effect be distinguished when an association
3- 24 12.6 50 12.2 74 12.3 0.6 between such a measurement and the incidence of cancer is
4- 37 10.2 66 11.4 103 11.0 0.4 found.
5- 60 10.7 122 11.3 182 11.1 0.3 In the design of our study, we matched subjects with
6- 38 8.9 72 8.8 110 8.8 0.3 controls for age, smoking habits and duration of storage of
7- 32 9.8 66 10.5 98 10.3 0.4 the serum sample. Mean vitamin E concentrations according
8- 30 9.7 58 8.5 88 8.9 0.4 to age at the time of blood collection showed no consistent
.9 24 8.1 49 8.0 73 8.1 0.4 pattern (or significant differences) (Table III); Table IV
shows the mean vitamin E levels according to smoking
category. Again, there was no clear pattern, though there
was a suggestion that serum vitamin E levels were lower in
though the cancer may not have been symptomatic or smokers than in non-smokers. Table V shows the mean
clinically apparent when the blood sample was collected. vitamin E levels according to duration of storage of the
This conclusion is supported by the fact that vitamin E levels serum sample. There was a general decline in vitamin E
were similarly low in the 50 clinically prevalent cases (includ- concentration with increasing storage time; on average, the
ing 23 skin cancers) at the time of blood collection and in concentration declined by 0.47mgl11 (or -5%) per year.
the 40 cancers that were diagnosed afterwards but still within Therefore, matching for duration of storage was critical
one year (including 8 skin cancers). while matching for age or smoking habits was much less so.
Our results suggest that it is unlikely that serum vitamin E Table VI summarises the prospective epidemiological
in the concentrations naturally found in well nourished evidence on serum vitamin E and cancer. Two of the seven
populations has any substantial effect on the risk of studied showed statistically significantly lower serum vitamin
developing cancer. It follows that any cancer inhibitory effect E levels in subjects who developed cancer compared with
suggested by the anti-oxidant activity of vitamin E or by controls who did not. Although the other five studies
some of the animal experimental evidence is not apparent at individually did not show statistically significant differences,
levels naturally found in man. four yielded differences in the same direction and one
Table VI A summary of the epidemiological studies of serum vitamin E and cancer
No. of Mean difference in
Approximate mean vitamin E (mgl- l). Published
Site of cancer time to diagnosis Cancer subjects minus controls. statistical
Study Sex cancer subjects controls ofcancer (years) (approximate s.e.) significance
Staihelin et al. (1984) Male All 115 308 4 -0.9 (0.5) NS
Wald et al. (1984) Female Breast 39 78 5 -1.3 (0.5) P<0.025
Willett et al. (1984) Both All 111 210 3 -1.0 (0.6) NS
Nomura et al. (1985) Male 5 Sites 284 302 5 0.0 (0.3)b NS
Salonen et al. (1985) Both All 51 51 2 -0.1 (0.3)a NS
Menkes et al. (1986) Both Lung 99 196 5 -1.4 (0.5) P<0.001
Present study Male All 271 533 3 -0.2 (0.3) NS
All -0.43 (0.14)c P=0.003
aStandard error (s.e.) was based on a vitamin E standard deviation of 1.6mgl F' estimated from one published P value; bse was based on a
vitamin E standard deviation of 4.0mg1-' as found in the present study; cThe overall average across studies was calculated as an average of
the individual mean differences, each weighted inversely according to its variance; NS=not statistically significant (P>0.05).72 N.J. WALD et al.
showed no difference at all. Taken as a whole, the seven
studies show an inverse association between serum vitamin E
and cancer, an association which is unlikely to be due to
chance. Our own results suggest one explanation for this
association, namely that the cancer caused the low vitamin E
levels rather than the reverse. It is, however, probably not
the only explanation. It is not, for example, a satisfactory
explanation for the inverse association shown between plasma
vitamin E and breast cancer in women reported by Wald et
al., 1984 (a result which requires independent corroboration)
because only 6 of 43 cases were diagnosed within 2 years of
blood collection. The extent to which it can offer a full
explanation for the results from the other studies cited in
Table VI would rest on the outcome of a statistical analysis
of the differences in vitamin E levels in cancer subjects and
controls in these studies classified by time to diagnosis.
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